Table 5.

Reporting quality assessment of included RCTs using the CONSORT statement and harms-assessment extension

Variable	Toprak et al24	Daman et al22	Palmer et al38	Reychler et al41	Sahin et al23
Title and abstract*	+	+	−	+	+
Background*	+	+	+	+	+
Participants	+	+	+	+	+
Interventions	+	+	+	+	+
Objectives	+	+	+	+	+
Outcomes*	+	−	−	−	−
Sample size	+	+	+	−	−
Randomization: sequence generation	+	+	+	+	−
Randomization: allocation concealment	−	−	−	+	−
Randomization: implementation	+	−	−	−	−
Blinding (masking)	+	+	−	+	−
Statistical methods*	−	−	+	−	−
Participant flow*	+	−	+	+	−
Recruitment	+	−	+	+	−
Baseline data	+	+	+	+	+
Nos. analyzed*	+	−	+	+	−
Outcomes and estimation*	+	−	+	−	−
Ancillary analysis*	−	−	−	−	−
Adverse events*	+	+	−	−	+
Interpretation*	+	+	+	+	−
Generalizability*	+	−	−	+	−
Overall evidence*	+	−	+	−	−

Abbreviations: −, does not meet requirements; +, meets requirements.

^⁎Assessment based on CONSORT statement and harm-extension.³⁴